tesamorelin ipamorelin stack or combination + — 13 mg – GHRH / GHS-R Dual Pathway Tesamorelin and Ipamorelin Stack: Top

pulsatility as well as sustained, dose-dependent increases in [growth hormone] and IGF-I levels in healthy adults.11 9 In 1999, a human trial with 40 total volunteers concluded that ipamorelin at multiple doses induces growth hormone secretion at sufficient levels to be biologically effective, with peak concentration arriving within an hour.12 These studies examined the two peptides separately, but their results validate the mechanisms of action that underlie the reason that CJC-1295 and ipamorelin are used together

Cell research 33(5):337-338, 2023

Kozakova M, Palombo C, Paterni M, Dekker J, Flyvbjerg A, Mitrakou A, Gastaldelli A, Ferrannini E

MV contributed to data interpretation and supervised clinical development at Nestl Health Science

Supervised delivery of such interventions is lacking in most countries and even where this support exists, uptake and adherence is poor